FDA Approves Ervebo (Ebola Zaire Vaccine, Live) for the Prevention of Disease Caused by Zaire Ebolavirus
KENILWORTH, N.J.--(BUSINESS WIRE) December 20, 2019 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Ervebo® (Ebola Zaire Vaccine, Live)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Canada Health | Drugs & Pharmacology | Ebola | Ebola Vaccine | Food and Drug Administration (FDA) | Merck | USA Health | Vaccines